NNVC Keeping it real board for pro and con discussions Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC Keeping it real board for pro and con discussions

NNVC 1.220

-3.2%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Rawnoc

12/29/2014 4:21:09 PM

of 326

Zincfinger sees the light....

Msg 1977 of 1977 at 12/29/2014 11:06:00 AM by

zincfinger

More than two months and still havent sent Ebola drug for testing?

" regarding when the various candidates would be ready for shipment to USAMRIID as Doc Seymour stated on 10/31 that, 'We're shooting for a mid-November ship date...' " (in a post by Puffer)

IMHO it's becoming pretty clear that an "Achilles Heel" of NNVC is production. Either that or NNVC is deliberately dragging their feet before further testing, as with the diversion for Ebola when their time frame is not remotely short enough to allow potential use or probably even testing in the field in this outbreak even if it drags on until the end of 2015.

The FDA may be, for example, requiring more consistency of size in the micelles than is achievable with current technology. Or maybe the animals from the last experiment were kept around after the official end of it (which was terminated after the end of the expected death period and not long enough to look for long term safety problems directly (as opposed to inferences made from the condition of organs etc).

IMHO it's difficult to see how this two months plus time for producing Ebola drug could possibly have failed to delay the Flucide work.

And still no final word on the sale of the manufacturing facility to NNVC. Still only promises and some things have been promised ever since the company was formed and still not delivered.

Until and if that sale is finalized. that facility, the ONLY asset of NNVC/Theracour that has solid (and very substantial) value totally independent of the value of the technology (because it is so easy to convert to standard production that Diwan has already speculated on the possibility of LEASING it out! (a truly amazing thing to have gone into considering how long it's taking to produce drug Flucide and now Ebolacide!) A number of Ebola drugs and multiple vaccines will be doing Phase IIs in the field, very possibly even phase III's while NNVC is still in animal testing. For THAT NNVC delayed Flucide?

Ownership of the manufacturing facility appears to be Diwan's "insurance policy" against a possible failure of the technology: if a show stopper should occur, Diwan/Theracour will be in excellent shape with a valuable manufacturing facility that could be sold or rented for use in manufacture of a wide range of drugs with very little conversion. NNVC would be left with nothing. And that's the way it will be until and if a sale is finalized.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next